Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Consortium for Globalization of Chinese Medicine (CGCM) is a non-profit international academic organization dedicated to the advancement and modernization of Traditional Chinese Medicine (TCM). Founded in 2003, the consortium facilitates global collaboration between leading universities, research institutes, and pharmaceutical companies to establish evidence-based standards for herbal products. CGCM focuses on quality control, regulatory affairs, and clinical trial methodologies to integrate TCM into mainstream global healthcare. By fostering industrial-academic partnerships, the organization aims to transform traditional knowledge into standardized botanical drugs that meet international regulatory requirements. The consortium currently includes over 150 member institutions worldwide, serving as a central hub for TCM research and globalization efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hong Kong Consortium for Globalization of Chinese Medicine.